Skip to content
HowShorted

aTyr Pharma, Inc. short interest in 2022

In 2022, aTyr Pharma, Inc.'s disclosed short interest ran from 2.27% of shares outstanding on 14 Jan 2022 to 1.00% on 30 Dec 2022, a change of -1.27 percentage points. The year's high was 2.27% on 14 Jan 2022 and its low 1.00% on 30 Dec 2022, averaging 1.47% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.82 days on 15 Feb 2022. Full history: aTyr Pharma, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for aTyr Pharma, Inc. in 2022

2022 in figures

Start of year
2.27% (14 Jan 2022)
End of year
1.00% (30 Dec 2022)
Change
-1.27 pp
High
2.27% (14 Jan 2022)
Low
1.00% (30 Dec 2022)
Average
1.47%
Highest days to cover
6.82 (15 Feb 2022)
SEC filings marked
9

Every report in 2022

aTyr Pharma, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20222.27%1.94
31 Jan 20222.19%4.84
15 Feb 20222.18%6.82
28 Feb 20222.01%5.59
15 Mar 20221.82%5.20results (8-K), 10-K filed
31 Mar 20221.64%2.22
14 Apr 20221.50%3.14results (8-K)
29 Apr 20221.49%4.88
13 May 20221.44%4.03results (8-K), 10-Q filed
31 May 20221.22%4.37
15 Jun 20221.23%4.58
30 Jun 20221.39%3.71
15 Jul 20221.18%4.78
29 Jul 20221.05%1.57
15 Aug 20221.13%2.2910-Q filed, results (8-K)
31 Aug 20221.19%1.66
15 Sep 20221.38%3.86
30 Sep 20221.60%5.38
14 Oct 20221.48%4.30
31 Oct 20221.59%5.39
15 Nov 20221.04%5.36results (8-K), 10-Q filed
30 Nov 20221.12%4.28
15 Dec 20221.04%1.96
30 Dec 20221.00%2.14

See also: aTyr Pharma, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.